Safety and Efficacy of Interferon-Gamma 1b in Patients With Candidemia
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
A randomized open label interventional phase 2 pilot study to evaluate safety and efficacy of
recombinant Interferon-Gamma 1b in patients with candidemia.